Weaver C. Barksdale & Associates’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-154
Closed -$13K 518
2017
Q2
$13K Sell
154
-46
-23% -$3.43K 0.02% 221
2017
Q1
$13K Buy
200
+20
+11% +$1.32K 0.02% 235
2016
Q4
$12K Buy
180
+31
+21% +$1.94K 0.02% 255
2016
Q3
$10K Sell
149
-5
-3% -$338 0.02% 271
2016
Q2
$10K Buy
154
+26
+20% +$1.61K 0.02% 252
2016
Q1
$8K Hold
128
0.01% 322
2015
Q4
$9K Buy
128
+5
+4% +$325 0.01% 286
2015
Q3
$8K Buy
+123
New +$8.27K 0.01% 308

Other funds holding PRXL

Weaver C. Barksdale & Associates's PRXL Position: Q3 2017 in Review

Weaver C. Barksdale & Associates sold out of Parexel International Corp (PRXL) in Q3 2017, closing a stake of 154 shares — an estimated $13K sold.

Weaver C. Barksdale & Associates first reported a position in PRXL in Q3 2015 and held it in 8 quarters. The position peaked at $13K in Q2 2017. 246 funds tracked by Wall St. Rank hold PRXL as of Q3 2017.

  • Weaver C. Barksdale & Associates reported no remaining Parexel International Corp position as of Q3 2017 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 154 Parexel International Corp shares in Q3 2017, an estimated $13K.
  • Weaver C. Barksdale & Associates first reported a position in Parexel International Corp in Q3 2015 and held it in 8 quarters.
  • Weaver C. Barksdale & Associates's Parexel International Corp position peaked at $13K in Q2 2017.
  • 246 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2017, filed 12 Oct 2017.